^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    astragalus polysaccharides  (PG2)

    i
    Other names: PG 2, PG2 Lyo injection, injectable astragalus polysaccharide, PG2, PHN013, PHN011, PHN012, Xue Bao PG2
    Associations

    News

    Trials
    Company:
    PhytoHealth Corp
    Drug class:
    Immunostimulant
    Related drugs:
    Associations

    News

    Trials
    1year
    PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients (clinicaltrials.gov)
    P2, N=36, Recruiting, PhytoHealth Corporation | Trial completion date: Dec 2022 --> Jun 2026 | Trial primary completion date: Dec 2022 --> Dec 2025
    Trial completion date • Trial primary completion date
    |
    astragalus polysaccharides  (PG2)
    1year
    PH-CP028: PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer (clinicaltrials.gov)
    P2, N=48, Completed, PhytoHealth Corporation | Active, not recruiting --> Completed
    Trial completion
    |
    astragalus polysaccharides  (PG2)
    over2years
    Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue (clinicaltrials.gov)
    P2/3, N=13, Terminated, PhytoHealth Corporation | N=210 --> 13
    Enrollment change
    |
    astragalus polysaccharides  (PG2)
    over2years
    PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer (clinicaltrials.gov)
    P2, N=48, Active, not recruiting, PhytoHealth Corporation | Recruiting --> Active, not recruiting | Trial completion date: Dec 2025 --> Feb 2025 | Trial primary completion date: May 2023 --> Feb 2023
    Enrollment closed • Trial completion date • Trial primary completion date
    |
    astragalus polysaccharides  (PG2)